Thiazolidinedione use, fluid retention, and congestive heart failure: A consensus statement from the American Heart Association and American Diabetes Association

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Diabetes care 2004, Vol.27 (1), p.256-263
Hauptverfasser:	NESTO, Richard W, BELL, David, YOUNG, Lawrence H, KAHN, Richard, BONOW, Robert O, FONSECA, Vivian, GRUNDY, Scott M, HORTON, Edward S, LE WINTER, Martin, PORTE, Daniel, SEMENKOVICH, Clay F, SMITH, Sidney
Format:	Artikel
Sprache:	eng
Schlagworte:	Biological and medical sciences Cardiology. Vascular system Complications and side effects Congestive heart failure Diabetes. Impaired glucose tolerance Edema - chemically induced Edema - epidemiology Endocrine pancreas. Apud cells (diseases) Endocrinopathies Heart Heart Failure - chemically induced Heart Failure - epidemiology Heart failure, cardiogenic pulmonary edema, cardiac enlargement Humans Hypoglycemic Agents - adverse effects Medical sciences Physiological aspects Risk factors Safety Thiazolidinediones Thiazolidinediones - adverse effects Type 2 diabetes Weight Gain
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!